GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GSK PLC (NYSE:GSK) » Definitions » Insider Ownership

GSK (GSK) Insider Ownership : 0.20 % (As of Apr. 27, 2024)


View and export this data going back to 1987. Start your Free Trial

What is GSK Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, GSK's insider ownership is 0.20%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, GSK's Institutional Ownership is 6.35%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, GSK's Float Percentage Of Total Shares Outstanding is 0.00%.


GSK Insider Ownership Historical Data

The historical data trend for GSK's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GSK Insider Ownership Chart

GSK Historical Data

The historical data trend for GSK can be seen below:

2023-06-30 2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31
Insider Ownership 0.40 0.40 0.40 0.40 0.40 0.40 0.40 0.40 0.43 0.20

GSK Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.


GSK (GSK) Business Description

Address
980 Great West Road, Brentford, Middlesex, GBR, TW8 9GS
In the pharmaceutical industry, GSK ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.

GSK (GSK) Headlines

From GuruFocus

GSK Enters Agreement to Acquire Aiolos Bio

By Business Wire 01-09-2024

WELCH & FORBES LLC Buys 3, Sells 2 in 4th Quarter

By GuruFocus Research GuruFocus Editor 02-02-2023

Signature Wealth Management Group Buys 3, Sells 2 in 4th Quarter

By GuruFocus Research GuruFocus Editor 01-10-2023

Top 5 4th Quarter Trades of JTC Employer Solutions Trustee Ltd

By GuruFocus Research GuruFocus Editor 01-18-2023